Connect with us

S&P Futures, Global Stocks Rebound From Friday’s Rout Ahead Of Fed Speaker Parade

S&P Futures, Global Stocks Rebound From Friday’s Rout Ahead Of Fed Speaker Parade

US equity futures and global stocks recovered some of their Friday losses after hitting a four-week low earlier in Monday’s session, as investors dipped…

Published

on

S&P Futures, Global Stocks Rebound From Friday's Rout Ahead Of Fed Speaker Parade

US equity futures and global stocks recovered some of their Friday losses after hitting a four-week low earlier in Monday's session, as investors dipped their toe and bought risk after last week’s surprise hawkish shift by the Fed even as the dollar hovered below a 10-week high. S&P 500 futures rebounded after spending most of the Asia session in the red, while Europe's Stoxx 600 Index also recovered from an earlier loss, with U.K. grocer Wm Morrison Supermarkets surging 32% after rejecting an unsolicited takeover bid, sending shares of peers Tesco Plc and J Sainsbury Plc higher.

"It just looks like a bit of relief rally following last week’s heavy sell-offs,” said MUFG analyst Lee Hardman. “Market participants will be watching closely comments from Fed officials in the week ahead to see if any push back against hawkish market repricing following last week’s FOMC meeting”

Last Friday, St. Louis Fed President James Bullard fueled a sell-off by saying the shift toward faster policy tightening was a “natural” response to economic growth and particularly inflation moving quicker than anticipated as the country reopens from the coronavirus pandemic.

“The Fed’s pivot to begin the tightening discussion caught most by surprise, but markets began discounting this inevitable process months ago in our view,” Morgan Stanley analysts wrote in a report. “It’s exactly what the mid-cycle transition is all about, and fits nicely with our narrative for choppier equity markets and a 10-20% correction for the broader indices this year.”

“We have another possibly two years before the Fed starts to take action,” John Woods, Asia Pacific chief investment officer at Credit Suisse Group AG, said on Bloomberg Television. “So I do anticipate there will be a period of choppy, sideways trading as the volatility associated with this debate in the Fed is reflected in pricing, but absolutely I take the view that yields will tick a little higher.”

Earlier in the session, growing fears that a faster-than-expected policy tightening by the Federal Reserve would sink the reflation trade and send the US economy into recession amid dismal new estimates of r*, spurred caution across markets. The 30-year Treasury yield dropped below 2% for the first time since February as Asian markets plunged, with the Nikkei 225 down 4% at one point, forcing the BOJ to buy ETFs to stabilize risk for the first time since April.

While meme stocks were once again bid, cryptocurrency-exposed stocks tumbled in U.S. premarket after Bitcoin crashed over the weekend and into Monday amid a fresh crackdown by China whose digital yuan is proving to be a total disaster so far, prompting Beijing to take out its anger on cryptocurrencies. Bitcoin dropped 10%, sliding below $33,000 amid weakening appetite for riskier assets and China ordered payment platform Alipay and domestic banks to not provide services linked to trading of virtual currencies. The Chinese city of Ya’an was  said to have started a crackdown on crypto mining firms.

As a result, Cryptocurrency-exposed stocks slumped: Riot Blockchain (RIOT) plunged 6.5% in premarket trading and Marathon Digital (MARA) drops 7%, while Coinbase (COIN) slips 2.3% and Ebang (EBON) declines 4.4%. Here are some other notable pre-movers today:

  • Luokung Technology (LKCO) climbs 16% after announcing its eMapgo Technologies unit won a contract to provide a traffic control network in China’s Jiangxi Province.
  • Raven Industries surges 48% after the Agnelli family’s CNH Industrial agreed to buy the U.S. precision agriculture-technology company for about $2.1 billion.
  • Torchlight Energy Resources (TRCH) jumped as much as 63% after the stock was touted on Reddit as a potential short squeeze. Other meme stocks also climbed: AMC Entertainment (AMC) advances 3.4% and GameStop (GME) gains 1.8%, while Clover Health (CLOV) rises 1%

MSCI’s All Country World Index was down 0.2%, trimming some losses after hitting its lowest since May 24.

Europe's Stoxx 600 rose 0.3% and was near session highs after dropping as much as -0.6% earlier, with the Stoxx Europe 600 Basic Resources Index falling as much as 2.1%, down for a 6th consecutive day, as iron ore retreated after China’s inbound steel scrap spiked to the highest in more than two years, threatening the role of the ore. Here are some of the biggest European movers today:

  • Wm Morrison shares soar as much as 30%, rising above the level of the rejected bid from private equity firm Clayton Dubilier & Rice.
  • Peers also gain as analysts see potential for more takeover activity for the sector. J Sainsbury +5.7%, Marks & Spencer +4.1%, Tesco +3.2%
  • Ocado rises 5.3%, also boosted by a Morgan Stanley upgrade
  • Kerry Group gains as much as 3.2%, best performer in the Stoxx 600 food, beverage and tobacco subgroup, after agreeing to buy preservation tech company Niacet for EU853m. The acquisition is a strong strategic fit, according to Goodbody.
  • Ontex gains as much as 7.5% after the Belgian diaper maker predicted stable like-for-like revenue for 2021, with a return to growth from 2Q, and committed to 2023 targets.
  • Nordic Semiconductor slides as much as 7.3% to the lowest since May 20 after Pareto Securities double-downgrades the stock to sell from buy, the only sell rating among analysts tracked by Bloomberg.
  • European travel stocks drop after the U.K. government signaled it will keep restrictions on overseas travel in place for the time being due to a surge in Covid-19 infections and the risk of new variants taking hold.

Earlier in the session, stocks in Asia took their cue from Wall Street’s falls on Friday but European shares bucked the trend, with the pan-European STOXX 600 index up 0.3% by mid-morning trade in London.  Japan’s Nikkei led declines with a 3.6% drop and dipped below 28,000 for the first time in a month, while MSCI’s broadest index of Asia-Pacific shares outside Japan fell 1.4%. Chinese blue chips lost 0.7%.

“The interesting part about this correction is that it was lagged, so it took a while for the market to sort through the news,” said Sebastien Galy, senior macro strategist at Nordea Asset Management. “The situation in reality is actually pretty good - the Fed is stabilizing inflation...Cyclical sectors may have overshot the market in the short term and so you may have a bit of pressure on the sector.”

In rates, the 10-year U.S. Treasury yields recovered to 1.4313% after falling to their lowest since Feb. 24 at 1.3540%. The yield curve - measured by the spread between two- and 30-year yields - earlier hit its flattest since late January, and as investors brought forward rate hike expectations while lowering the longer-term outlook for growth and inflation.

In FX, the U.S. dollar hovered just below the 10-week high touched on Friday versus major peers, following its biggest weekly advance in more than a year. The euro traded above its lowest against the dollar since April 6 at $1.1895 on Monday, dropping from as high as $1.21457 last Tuesday. Sterling recovered some ground, to trade 0.6% higher at $1.3868 after sliding to its lowest since April 16 on Friday.

Commodity-linked currencies have also suffered, with the Australian dollar hovering above a six-month low at $0.7495. The trade-sensitive New Zealand and Australian dollars led G-10 gains and the dollar slipped against peers on a pick-up in global risk appetite. The kiwi rose as much as 0.5% to 0.6973, and the Aussie gained as much as 0.6% to 0.7522 in its biggest move since June 4. The haven Swiss franc traded close to the bottom of the leader board; moves came as U.S. equity futures rose and European stocks pared losses.

“Last week’s dollar rally is a combination of expectations and positioning (sold dollars), a concern that the Fed is ‘behind the curve’ (and therefore must do more and earlier than expected), and that stock markets have started to lose ground which makes the dollar strengthen as the most defensive currency,” Filip Carlsson, junior quantitative strategist at SEB, said in a morning note. “We still see this as a correction and not the beginning of a new trend.”

In commodities, gold rebounded 1.2% to $1,784 an ounce on Monday, looking to snap a six-day losing streak, but remained near the lowest since early May. Three-month copper on the London Metal Exchange fell to its lowest since April 15, following an 8.6% drop last week, the biggest weekly fall since March 2020.

Crude oil rose for a second day, underpinned by strong demand during the summer driving season and a pause in talks to revive the Iran nuclear deal that could indicate a delay in resumption of supplies from the OPEC producer. Brent crude futures rose 0.2% to $73.64 a barrel, while WTI crude rose 0.3% to $71.83 a barrel.

As noted above, cryptocurrencies fell back, hurt by a general worsening of investor sentiment as well as China’s ongoing crackdown on Bitcoin mining and the prospect of tighter regulations elsewhere.

Traders will be paying close attention to this week’s appearances by Fed policy makers, including Chair Jerome Powell, for more guidance on a possible timeline for tapering asset purchases. Last week, markets were shocked when the Fed sped up its expected pace of policy tightening amid optimism about the labor market and heightened concerns over price pressures in the recovery from the pandemic. And after last week's FOMC shock which was compounded by Bullard even more hawkish comments on Friday morning, we will get even more Fed speakers today including a repeat appearance by James Bullard and Robert Kaplan both of whom are scheduled to speak later on Monday, while John Williams and Jerome Powell will speak later this week. Bullard said on Friday that inflation risks may warrant the Fed to begin raising interest rates next year. ECB President Christine Lagarde also speaks before the European Parliament on Monday.

Market Snapshot

  • S&P 500 futures up 0.3% to 4,165.50
  • STOXX Europe 600 up 0.3% to 453.50
  • MXAP down 1.5% to 204.41
  • MXAPJ down 1.1% to 687.86
  • Nikkei down 3.3% to 28,010.93
  • Topix down 2.4% to 1,899.45
  • Hang Seng Index down 1.1% to 28,489.00
  • Shanghai Composite up 0.1% to 3,529.18
  • Sensex little changed at 52,371.90
  • Australia S&P/ASX 200 down 1.8% to 7,235.31
  • Kospi down 0.8% to 3,240.79
  • German 10Y yield rose 0.3 bps to -0.197%
  • Euro up 0.2% to $1.1891
  • Brent Futures up 0.3% to $73.71/bbl
  • Gold spot up 1.1% to $1,783.66
  • U.S. Dollar Index down 0.11% to 92.12

Top Overnight News from Bloomberg

  • Bitcoin slid Monday amid fraying appetite for riskier investments and an intensifying cryptocurrency crackdown in China
  • President Emmanuel Macron and far-right leader Marine Le Pen both fared worse than expected in the first round of France’s regional election, in a disappointing twist for the two main contenders in the 2022 presidential race. The main winners were the traditional right, the Republicans, who averaged 28% across the country, according to an Ifop poll
  • The U.S. is preparing additional sanctions against Russia for the poisoning of opposition leader Alexey Navalny, National Security Adviser Jake Sullivan said
  • The U.K. government signaled it will keep restrictions on overseas travel in place for now to control a surge in coronavirus infections and the risk of new variants of the virus taking hold
  • The currencies of Brazil, Russia, the Czech Republic, South Africa and Hungary-- countries that delivered multiple rate hikes or are expected to do so soon -- are retaining quarterly gains and outperforming peers. More may join their ranks, with tightening expectations growing for countries including Chile and South Africa as economic activity and inflation roar back from a pandemic-driven slump
  • Chinese officials will spend the next month or so fanning out across the country to check on capacity curbs in the steel industry. The program to rein in emissions from the highly pollutive sector has foundered after a spike in prices encouraged mills to churn out record quantities of the alloy

Quick look at global markets courtey of Newsquawk

APAC equities were mostly negative as the downbeat mood from Wall Street reverberated into the region following the hawkish Friday remarks from the Fed’s 2022-voter Bullard, with both the Dow and S&P 500 hitting session lows in the final minutes of trading and the former posting its worst weekly loss since October. US equity futures extended on Friday’s losses ahead of a week teeming with Fed speakers – including Fed Chair Powell’s testimony to Congress tomorrow; however, as the European morning progresses US equity futures pared back this underperformance and are now firmer on the session, ES +0.5%. Back to APAC, the ASX 200 (-1.8%) was under pressure from its heavyweight mining and financials sectors, whilst the Nikkei 225 (-3.3%) plumbed the depths in early trade before dipping below the 28k mark – with underperformance seen across its industrial and auto sectors. Losses in South Korea’s KOSPI (-0.8%) were somewhat cushioned in early trade as the country is poised to relax its social-distancing rules starting next month amid slowing COVID cases, whilst prelim trade figures were also constructive. Hang Seng (-1.0%) and Shanghai Comp (+0.1%) were mixed after both initially conformed to the soured risk tone with the latter more composed after finding buyers at around the 3,500 level and amid reports on Friday that Chinese officials are reportedly drafting plans to further loosen birth restrictions by 2025. Finally, 10yr JGB futures tracked gains across US and German counterparts as the fixed-income complex remains underpinned by the soured risk tone.

Top Asian News

  • Hong Kong to Cut Quarantine Time for Vaccinated Travelers
  • Evergrande Takes On Short Sellers With $400 Million Asset Sale
  • Apple Daily to Suspend Paper If Hong Kong Accounts Stay Frozen
  • China Risks Isolation in Quest for Virus Origin, Biden Aide Says

European equities kicked the session off on the backfoot, in-fitting with losses seen on Wall Street on Friday and overnight during the APAC session. The moves in equity markets took place in the wake of hawkish remarks from 2022 voter Bullard last Friday who cautioned that a quicker pace of tightening policy would be a natural response to economic growth and inflation. Note, developments in the rates market ahead of the European entrance hinted more of a potential policy mistake/ focus on the growth implications for the economy from a faster pace of Fed tightening as the US 10yr and 30yr cash yields dipped below 1.40% and 2.00% respectively. This prompted more of a preference towards safe-haven assets and helped explain the combination of softer equities/lower yields. That said, as the European session progressed price action reversed and indices are now firmer on the session (Euro Stoxx 50 +0.6%) – seemingly taking the lead from a resurgence in US futures, ES +0.5%. From a sector standpoint, the bias is towards a more anti-cyclical stance as Travel & Leisure, Basic Resources, Banks and Oil & Gas lag peers and indeed remain in the red in-spite of the general pick up in performance. As the reflation trade pauses for breath, direction for the market this week will likely be determined by the tone of Fed rhetoric amid a busy speaker slate. In terms of stock specifics, Morrisons (+32%) is the notable outperformer in Europe after receiving a GBP 2.30/shr (vs. Friday close of GBP 1.78/shr) takeover offer from CD&R. Morrisons rejected the bid, however, speculation remains that a higher offer will be presented at some stage with some reports touting potential interest from rival bidders such as Lone Star and Amazon. The prospect of sector consolidation has also provided support to the likes of Ocado (+3.8%), Sainsbury’s (+3.9%) and Marks & Spencer (+2.7%). Other deals to be aware of in the region include Vivendi (+0.3%) selling a 10% stake in Universal Music Group to Pershing Square, CNH Industrial (+1.8%) acquiring Rave Industries for USD 2.1bln and Generali (+1.3%) filing an offer document with CONSOB for a takeover bid for Cattolica.

Top European News

  • Agnellis’ CNH Industrial Acquires Raven for $2.1 Billion
  • Porsche to Make High-Performance Battery Cells in Germany
  • U.K. Housing Market Growth Slows as Record Prices Deter Buyers
  • Half of London Firms Plan for Home Working Five Days a Week

In FX, an unusually volatile start to the week following heavy declines in APAC equities, base metals and crypto currencies overnight that prompted a pronounced rally in US Treasuries and other safe haven assets like the Greenback and Yen to varying degrees. However, the Buck lost momentum as yields descended through key or psychological levels, like 1.40% in the 10 year benchmark and 2% in long bonds. Moreover, the DXY may have faded on technical grounds after reaching 92.375 and falling short of last Friday’s 92.408 peak, but retains an underlying bid just ahead of 92.000 as USTs drift down from best levels and rates tick up. Looking ahead, only May’s national activity index is scheduled on the data front, but Fed’s Bullard, Harker, Kaplan and Williams are all slated to speak and the former certainly gave the Dollar a boost last time out with some particularly hawkish comments.

  • NZD/GBP/AUD/EUR/JPY - All things considered, the Kiwi is holding up quite well around 0.6950 against its US counterpart and has clawed back losses vs its Antipodean peer after defending 1.0800 on the cross in the run up to Westpac’s Q2 NZ consumer survey tonight, while the Aussie is straddling 0.7500 against its US rival in wake of weaker than forecast prelim retail sales and against the backdrop of the aforementioned slide in copper, iron ore etc. Elsewhere, Sterling has reclaimed 1.3800+ status and is still trading mostly above 0.8600 vs the Euro even though the latter has rebounded from just under 1.1850 against the US Dollar again and is now eyeing offers/resistance into 1.1900 on the back of a firmer rebound in EGB yields. Meanwhile, the Yen is pivoting 110.00 where decent option expiry interest sits (1.2 bn) having contained losses to circa 110.26 before testing an upside chart level at 109.70.
  • CHF/CAD - The Franc has recovered some post-dovish SNB losses between 0.9237-07 parameters, but with little reaction to the Bank expanding the range of mortgage market indicators and providing a selection to the public as the number of housing loans offered by banks rises, or to latest weekly sight deposits showing a small rise in domestic balances. Similarly, the Loonie is off worst levels within a 1.2487-36 range, though still not getting a lot in the way of impetus from oil in advance of Canadian retail sales data on Wednesday.
  • SCANDI/EM - The Nok continues to underperform following only a fleeting or knee-jerk rise when the Norges Bank tightened rate hike guidance and raised its depo path profile last Thursday, but the Sek is displaying some resilience and patience given the latest vote of no confidence in Swedish PM Lofven who will provide an update within one-week on whether he will resign or call for snap elections. Elsewhere, the Zar and Mxn are bucking a broadly weaker trend vs the Usd on relative strength in Gold and WTI respectively, but the Cnh/Cny are softer after a lower PBoC midpoint fix and unchanged LPRs, the Try is back down near record lows and Rub off recent recovery highs amidst more Russian-US strains on potential further sanctions.

In commodities, WTI and Brent have commenced the European session with modest gains after somewhat choppy performance overnight throughout which newsflow has been quite light aside from geopolitical updates. Currently, the benchmarks post gains of USD 0.30/bbl each with this marginal upside following similar performance in US futures which, as mentioned, recuperated from overnight losses. On the geopolitical front Raisi secured victory in the Iranian Presidential elections as expected though this appointment should not have much, if any, impact on nuclear negotiations due to the Supreme Leader having the final say. In terms of the latest tone of discussions the US National Security Advisor Sullivan said talks are going in the right direction and EU representatives believe an agreement is very close. However, bear in mind an Iranian spokesperson has stated that a new JCPOA can never be negotiated placing the impetus very firmly on ongoing talks. Returning to crude itself and following similar bullish commentary from other desks BofA says that oil could briefly hit USD 100/bbl in 2022 and looks for Brent to average USD 75/bbl throughout that year, given tighter balances between supply and demand. Moving to metals, spot gold and silver are firmer benefitting from an initially choppy but now notably subdued USD alongside a very modest pullback in yields; posting gains of circa 1.0% but off respective highs of USD 1785/oz and USD 26.13/oz. Elsewhere, base metals are pressured but stable when compared to recent price action particularly for the likes of LME copper given last week’s losses.

US Event Calendar

  • 8:30am: May Chicago Fed Nat Activity Index, est. 0.70, prior 0.24

DB's Jim Reid concludes the overnight wrap

The tumultuous couple of days or so in bond markets following the FOMC has carried on overnight with another big rally. Given these extreme moves one of the most important things this week will likely be Fed speakers responding to the meeting and subsequent market reaction. Make no mistake the market reaction was fairly extreme to what at the end of the day is a Fed that themselves suggest they are still around 2 and a quarter years away from raising rates. Although the US 10yr yield move wasn’t that dramatic over the full week (-1.4bps), the curve move was extreme as 5yr yields rose +13.6bps but 30yr yields rallied -12.5bps. The 5yr-30yr yield curve saw the largest one week flattening (-26.1bps) in nearly ten years. Overnight 5 year US yields have rallied -2bps but 30 years have rallied another -6.6bps, so the aggressive flattening continues. I can’t say the move makes much sense but one has to respect the signals for now. Some say it proves the Fed won’t ever be reckless in their pursuit of FAIT and inflation will be contained. Some say it’s showing the start of a policy error. For me, with the upside risks to inflation, the Fed simply got a bit closer to a realistic assessment of the balance of risks. We will see what the follow through is this week.

As for those Fed speakers, the highlight on paper will be Fed chair Powell’s testimony tomorrow before the House select subcommittee on the Covid-19 crisis. However, Powell's discussion is expected to center on the Fed's policy response and we may not get too much FOMC insight.

Before that Bullard (non-voter, dove) and Kaplan (non-voter, hawk) discuss the economic outlook today. They both have expressed a preference for liftoff in 2022, though for somewhat different reasons. Bullard rocked markets on Friday by suggesting his 2022 core PCE inflation forecast of 2.5% as justifying a hike in late 2022, whereas Kaplan has recently focused on financial stability concerns. So there might not be much more for these guys to say today but New York President Williams (voter, dove) later this afternoon might have fresh views especially on the taper given the responsibility for the Fed’s balance sheet that his region has.

Before Powell tomorrow, San Francisco's Daly (voter, dove) and Cleveland's Mester (non-voter, hawk) will be speaking at separate events while on Wednesday, we will hear from Fed Governor Bowman (neutral), Atlanta President Bostic (voter, neutral) and Boston's Rosengren (non-voter, hawk). Bostic will appear again on Thursday alongside Philadelphia's Harker (non-voter, hawk), the latter of which has also been a proponent of tapering asset purchases sooner rather than later. We’ll also have repeat performances from Williams, Bullard, Kaplan and Mester over the week. So plenty of potential market moving jawboning. The Fed were very coordinated in playing down inflation risks after the first mega CPI print six weeks ago so it’ll be interesting if they all sing from the same song sheet this week. I can’t help thinking that the debate is starting to liven up at the Fed now but will the last few days of market moves scare them?

Moving onto the data the biggest highlight will be the release of the June flash PMIs on Wednesday from around the world, which will give us an initial indication of how the global economy has performed into the end of Q2. The final May PMIs showed that growth was still maintaining decent momentum, with the Euro Area composite PMI coming in at 57.1, the strongest in over 3 years, while the US composite PMI was at 68.7, which is the strongest since the data goes back to in October 2009. Another release of note will be the German Ifo’s business climate indicator for June (Thursday), which rose to a 2-year high last month of 99.2.

Friday will be a key day with inflation being dissected within the US personal income and University of Michigan releases. Clues to Core PCE will be the key in the former with the 5-10 year inflation expectations important on the latter. On this, May’s number dipped 0.2% from April’s 3%. So all eyes on this.

The main monetary policy decision this week comes from the Bank of England on Thursday, where our economists write in their preview (link here) that they expect the MPC to remain cautiously optimistic around the recovery, keeping the policy rate on hold at 0.1% and maintaining the target stock of QE at £895bn. They think that stronger growth, labour market and inflation data thus far should tilt the policy statement in a slightly more hawkish direction than in May. Nevertheless, something else to watch out for in the UK will be the latest data on Covid-19, as the spread of the delta variant has led to a noticeable rise in cases and hospitalisations over recent weeks, albeit still at relatively low levels compared to earlier in the year. Russia, Germany and Portugal have now also reported an increasing spread of Delta with a big story in the FT today about the variants small but growing footholds across Europe. This will capture some attention. The rest of the week’s main events will be in the day by day list at the end.

As discussed at the top, we are continuing to see a big flattening of the US treasury curve overnight with yields on 30y USTs down by -6.6bps to 1.949%, 10y USTs down -5.9bps to 1.38%, but those on 2y are up by +1bps. In a bad session for equities, the Nikkei (-3.37%), Hang Seng (-1.35%), Shanghai Comp (-0.22%) and Kospi (-1.04%) are all down. Meanwhile, futures on the S&P 500 are -0.56% and those on the Stoxx 50 are -0.92%. In commodities, DCE iron ore futures are down -4.96% while SHF steel rebar futures are down -2.06%.

Turning to politics, French President Macron and far-right leader Marine Le Pen both are likely to have fared poorly in a regional election in France where the turnout was at an all-time low of c. 33% (vs. c. 50% in last election). According to an Ifop poll, Le Pen’s National Rally got 19%, c. 10 points behind her performance in the last election while, Macron’s party took only 11% and is not expected to win any regions. Better performances came from the Conservative party that likely received 27% of votes while the Greens are likely to be at 12%. To know more on how the outcome of regional elections can have an impact on the French Presidential election in 2022 read this note from our European economists (link here).

Now back to last week, the key event was clearly the FOMC. The hawkish pivot from the Fed was highlighted by the dot plot now showing the 2023 median dot pricing in 2 rate hikes (25bps), compared to 0 hikes in March. Bond prices reacted strongly to the Fed announcement, with 10yr yields initially increasing over 8bps on Wednesday. However by the end of the week the yield curve flattened significantly, with longer terms yields falling sharply as investors grew in confidence that the Fed would rein in inflation or conversely that there may be a policy error in the offing. The hawkish pivot caused the US dollar index to increase +1.84% on the week – the largest one week rise in the greenback since September.

As we discussed at the top, over the course of the week the US 10yr yield move wasn’t that dramatic as they fell -1.4bps (-6.6bps Friday) to 1.438%, driven by a -10.1bp decline in inflation expectations, while real yields rose +9.0bps. 30yr US bond yields fell a more significant -12.5bps to 2.01% - their lowest close since mid-February. On the other hand 5yr yields finished the week +13.6bps higher to 0.87%. Overall that left the 5yr-30yr yield curve at late-September levels, after the largest one week flattening (-26.1bps) in nearly ten years. Other Sovereign bonds sold off as well with 10yr bund yields increasing +7.4bps, UK gilt yields up +4.5bps and French OAT yields up +6.4bps.

The rate volatility caused moves across asset classes, with equities seeing a twist of their own. The S&P 500 was down -1.91% (-1.31% Friday) as cyclicals such as banks (-8.10% on week) and energy (-5.40% on week) companies declined significantly on the lower rate and commodity price outcomes. On the other hand, high-growth stocks which do better in a low rate environment strongly outperformed with the NASDAQ “only” down -0.28% on the week, while the megacap tech NYFANG index rose +1.58% in its fifth straight weekly gain. Small caps stocks struggled in particular, declining -4.20%, but remain the outperformer on a YTD basis – up 13.3%, compared to the S&P 500’s +10.9% gain. In Europe there was a similar growth over cyclical rotation, and the STOXX 600 fell -1.19%, with the majority of losses (-1.58%) coming on Friday.

Tyler Durden Mon, 06/21/2021 - 07:08

Read More

Continue Reading

International

Red Candle In The Wind

Red Candle In The Wind

By Benjamin PIcton of Rabobank

February non-farm payrolls superficially exceeded market expectations on Friday by…

Published

on

Red Candle In The Wind

By Benjamin PIcton of Rabobank

February non-farm payrolls superficially exceeded market expectations on Friday by printing at 275,000 against a consensus call of 200,000. We say superficially, because the downward revisions to prior months totalled 167,000 for December and January, taking the total change in employed persons well below the implied forecast, and helping the unemployment rate to pop two-ticks to 3.9%. The U6 underemployment rate also rose from 7.2% to 7.3%, while average hourly earnings growth fell to 0.2% m-o-m and average weekly hours worked languished at 34.3, equalling pre-pandemic lows.

Undeterred by the devil in the detail, the algos sprang into action once exchanges opened. Market darling NVIDIA hit a new intraday high of $974 before (presumably) the humans took over and sold the stock down more than 10% to close at $875.28. If our suspicions are correct that it was the AIs buying before the humans started selling (no doubt triggering trailing stops on the way down), the irony is not lost on us.

The 1-day chart for NVIDIA now makes for interesting viewing, because the red candle posted on Friday presents quite a strong bearish engulfing signal. Volume traded on the day was almost double the 15-day simple moving average, and similar price action is observable on the 1-day charts for both Intel and AMD. Regular readers will be aware that we have expressed incredulity in the past about the durability the AI thematic melt-up, so it will be interesting to see whether Friday’s sell off is just a profit-taking blip, or a genuine trend reversal.

AI equities aside, this week ought to be important for markets because the BTFP program expires today. That means that the Fed will no longer be loaning cash to the banking system in exchange for collateral pledged at-par. The KBW Regional Banking index has so far taken this in its stride and is trading 30% above the lows established during the mini banking crisis of this time last year, but the Fed’s liquidity facility was effectively an exercise in can-kicking that makes regional banks a sector of the market worth paying attention to in the weeks ahead. Even here in Sydney, regulators are warning of external risks posed to the banking sector from scheduled refinancing of commercial real estate loans following sharp falls in valuations.

Markets are sending signals in other sectors, too. Gold closed at a new record-high of $2178/oz on Friday after trading above $2200/oz briefly. Gold has been going ballistic since the Friday before last, posting gains even on days where 2-year Treasury yields have risen. Gold bugs are buying as real yields fall from the October highs and inflation breakevens creep higher. This is particularly interesting as gold ETFs have been recording net outflows; suggesting that price gains aren’t being driven by a retail pile-in. Are gold buyers now betting on a stagflationary outcome where the Fed cuts without inflation being anchored at the 2% target? The price action around the US CPI release tomorrow ought to be illuminating.

Leaving the day-to-day movements to one side, we are also seeing further signs of structural change at the macro level. The UK budget last week included a provision for the creation of a British ISA. That is, an Individual Savings Account that provides tax breaks to savers who invest their money in the stock of British companies. This follows moves last year to encourage pension funds to head up the risk curve by allocating 5% of their capital to unlisted investments.

As a Hail Mary option for a government cruising toward an electoral drubbing it’s a curious choice, but it’s worth highlighting as cash-strapped governments increasingly see private savings pools as a funding solution for their spending priorities.

Of course, the UK is not alone in making creeping moves towards financial repression. In contrast to announcements today of increased trade liberalisation, Australian Treasurer Jim Chalmers has in the recent past flagged his interest in tapping private pension savings to fund state spending priorities, including defence, public housing and renewable energy projects. Both the UK and Australia appear intent on finding ways to open up the lungs of their economies, but government wants more say in directing private capital flows for state goals.

So, how far is the blurring of the lines between free markets and state planning likely to go? Given the immense and varied budgetary (and security) pressures that governments are facing, could we see a re-up of WWII-era Victory bonds, where private investors are encouraged to do their patriotic duty by directly financing government at negative real rates?

That would really light a fire under the gold market.

Tyler Durden Mon, 03/11/2024 - 19:00

Read More

Continue Reading

Spread & Containment

Fauci Deputy Warned Him Against Vaccine Mandates: Email

Fauci Deputy Warned Him Against Vaccine Mandates: Email

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

Mandating COVID-19…

Published

on

Fauci Deputy Warned Him Against Vaccine Mandates: Email

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

Mandating COVID-19 vaccination was a mistake due to ethical and other concerns, a top government doctor warned Dr. Anthony Fauci after Dr. Fauci promoted mass vaccination.

Coercing or forcing people to take a vaccine can have negative consequences from a biological, sociological, psychological, economical, and ethical standpoint and is not worth the cost even if the vaccine is 100% safe,” Dr. Matthew Memoli, director of the Laboratory of Infectious Diseases clinical studies unit at the U.S. National Institute of Allergy and Infectious Diseases (NIAID), told Dr. Fauci in an email.

“A more prudent approach that considers these issues would be to focus our efforts on those at high risk of severe disease and death, such as the elderly and obese, and do not push vaccination on the young and healthy any further.”

Dr. Anthony Fauci, ex-director of the National Institute of Allergy and Infectious Diseases (NIAID. in Washington on Jan. 8, 2024. (Madalina Vasiliu/The Epoch Times)

Employing that strategy would help prevent loss of public trust and political capital, Dr. Memoli said.

The email was sent on July 30, 2021, after Dr. Fauci, director of the NIAID, claimed that communities would be safer if more people received one of the COVID-19 vaccines and that mass vaccination would lead to the end of the COVID-19 pandemic.

“We’re on a really good track now to really crush this outbreak, and the more people we get vaccinated, the more assuredness that we’re going to have that we’re going to be able to do that,” Dr. Fauci said on CNN the month prior.

Dr. Memoli, who has studied influenza vaccination for years, disagreed, telling Dr. Fauci that research in the field has indicated yearly shots sometimes drive the evolution of influenza.

Vaccinating people who have not been infected with COVID-19, he said, could potentially impact the evolution of the virus that causes COVID-19 in unexpected ways.

“At best what we are doing with mandated mass vaccination does nothing and the variants emerge evading immunity anyway as they would have without the vaccine,” Dr. Memoli wrote. “At worst it drives evolution of the virus in a way that is different from nature and possibly detrimental, prolonging the pandemic or causing more morbidity and mortality than it should.”

The vaccination strategy was flawed because it relied on a single antigen, introducing immunity that only lasted for a certain period of time, Dr. Memoli said. When the immunity weakened, the virus was given an opportunity to evolve.

Some other experts, including virologist Geert Vanden Bossche, have offered similar views. Others in the scientific community, such as U.S. Centers for Disease Control and Prevention scientists, say vaccination prevents virus evolution, though the agency has acknowledged it doesn’t have records supporting its position.

Other Messages

Dr. Memoli sent the email to Dr. Fauci and two other top NIAID officials, Drs. Hugh Auchincloss and Clifford Lane. The message was first reported by the Wall Street Journal, though the publication did not publish the message. The Epoch Times obtained the email and 199 other pages of Dr. Memoli’s emails through a Freedom of Information Act request. There were no indications that Dr. Fauci ever responded to Dr. Memoli.

Later in 2021, the NIAID’s parent agency, the U.S. National Institutes of Health (NIH), and all other federal government agencies began requiring COVID-19 vaccination, under direction from President Joe Biden.

In other messages, Dr. Memoli said the mandates were unethical and that he was hopeful legal cases brought against the mandates would ultimately let people “make their own healthcare decisions.”

“I am certainly doing everything in my power to influence that,” he wrote on Nov. 2, 2021, to an unknown recipient. Dr. Memoli also disclosed that both he and his wife had applied for exemptions from the mandates imposed by the NIH and his wife’s employer. While her request had been granted, his had not as of yet, Dr. Memoli said. It’s not clear if it ever was.

According to Dr. Memoli, officials had not gone over the bioethics of the mandates. He wrote to the NIH’s Department of Bioethics, pointing out that the protection from the vaccines waned over time, that the shots can cause serious health issues such as myocarditis, or heart inflammation, and that vaccinated people were just as likely to spread COVID-19 as unvaccinated people.

He cited multiple studies in his emails, including one that found a resurgence of COVID-19 cases in a California health care system despite a high rate of vaccination and another that showed transmission rates were similar among the vaccinated and unvaccinated.

Dr. Memoli said he was “particularly interested in the bioethics of a mandate when the vaccine doesn’t have the ability to stop spread of the disease, which is the purpose of the mandate.”

The message led to Dr. Memoli speaking during an NIH event in December 2021, several weeks after he went public with his concerns about mandating vaccines.

“Vaccine mandates should be rare and considered only with a strong justification,” Dr. Memoli said in the debate. He suggested that the justification was not there for COVID-19 vaccines, given their fleeting effectiveness.

Julie Ledgerwood, another NIAID official who also spoke at the event, said that the vaccines were highly effective and that the side effects that had been detected were not significant. She did acknowledge that vaccinated people needed boosters after a period of time.

The NIH, and many other government agencies, removed their mandates in 2023 with the end of the COVID-19 public health emergency.

A request for comment from Dr. Fauci was not returned. Dr. Memoli told The Epoch Times in an email he was “happy to answer any questions you have” but that he needed clearance from the NIAID’s media office. That office then refused to give clearance.

Dr. Jay Bhattacharya, a professor of health policy at Stanford University, said that Dr. Memoli showed bravery when he warned Dr. Fauci against mandates.

“Those mandates have done more to demolish public trust in public health than any single action by public health officials in my professional career, including diminishing public trust in all vaccines.” Dr. Bhattacharya, a frequent critic of the U.S. response to COVID-19, told The Epoch Times via email. “It was risky for Dr. Memoli to speak publicly since he works at the NIH, and the culture of the NIH punishes those who cross powerful scientific bureaucrats like Dr. Fauci or his former boss, Dr. Francis Collins.”

Tyler Durden Mon, 03/11/2024 - 17:40

Read More

Continue Reading

Government

Trump “Clearly Hasn’t Learned From His COVID-Era Mistakes”, RFK Jr. Says

Trump "Clearly Hasn’t Learned From His COVID-Era Mistakes", RFK Jr. Says

Authored by Jeff Louderback via The Epoch Times (emphasis ours),

President…

Published

on

Trump "Clearly Hasn't Learned From His COVID-Era Mistakes", RFK Jr. Says

Authored by Jeff Louderback via The Epoch Times (emphasis ours),

President Joe Biden claimed that COVID vaccines are now helping cancer patients during his State of the Union address on March 7, but it was a response on Truth Social from former President Donald Trump that drew the ire of independent presidential candidate Robert F. Kennedy Jr.

Robert F. Kennedy Jr. holds a voter rally in Grand Rapids, Mich., on Feb. 10, 2024. (Mitch Ranger for The Epoch Times)

During the address, President Biden said: “The pandemic no longer controls our lives. The vaccines that saved us from COVID are now being used to help beat cancer, turning setback into comeback. That’s what America does.”

President Trump wrote: “The Pandemic no longer controls our lives. The VACCINES that saved us from COVID are now being used to help beat cancer—turning setback into comeback. YOU’RE WELCOME JOE. NINE-MONTH APPROVAL TIME VS. 12 YEARS THAT IT WOULD HAVE TAKEN YOU.”

An outspoken critic of President Trump’s COVID response, and the Operation Warp Speed program that escalated the availability of COVID vaccines, Mr. Kennedy said on X, formerly known as Twitter, that “Donald Trump clearly hasn’t learned from his COVID-era mistakes.”

“He fails to recognize how ineffective his warp speed vaccine is as the ninth shot is being recommended to seniors. Even more troubling is the documented harm being caused by the shot to so many innocent children and adults who are suffering myocarditis, pericarditis, and brain inflammation,” Mr. Kennedy remarked.

“This has been confirmed by a CDC-funded study of 99 million people. Instead of bragging about its speedy approval, we should be honestly and transparently debating the abundant evidence that this vaccine may have caused more harm than good.

“I look forward to debating both Trump and Biden on Sept. 16 in San Marcos, Texas.”

Mr. Kennedy announced in April 2023 that he would challenge President Biden for the 2024 Democratic Party presidential nomination before declaring his run as an independent last October, claiming that the Democrat National Committee was “rigging the primary.”

Since the early stages of his campaign, Mr. Kennedy has generated more support than pundits expected from conservatives, moderates, and independents resulting in speculation that he could take votes away from President Trump.

Many Republicans continue to seek a reckoning over the government-imposed pandemic lockdowns and vaccine mandates.

President Trump’s defense of Operation Warp Speed, the program he rolled out in May 2020 to spur the development and distribution of COVID-19 vaccines amid the pandemic, remains a sticking point for some of his supporters.

Vice President Mike Pence (L) and President Donald Trump deliver an update on Operation Warp Speed in the Rose Garden of the White House in Washington on Nov. 13, 2020. (Mandel Ngan/AFP via Getty Images)

Operation Warp Speed featured a partnership between the government, the military, and the private sector, with the government paying for millions of vaccine doses to be produced.

President Trump released a statement in March 2021 saying: “I hope everyone remembers when they’re getting the COVID-19 Vaccine, that if I wasn’t President, you wouldn’t be getting that beautiful ‘shot’ for 5 years, at best, and probably wouldn’t be getting it at all. I hope everyone remembers!”

President Trump said about the COVID-19 vaccine in an interview on Fox News in March 2021: “It works incredibly well. Ninety-five percent, maybe even more than that. I would recommend it, and I would recommend it to a lot of people that don’t want to get it and a lot of those people voted for me, frankly.

“But again, we have our freedoms and we have to live by that and I agree with that also. But it’s a great vaccine, it’s a safe vaccine, and it’s something that works.”

On many occasions, President Trump has said that he is not in favor of vaccine mandates.

An environmental attorney, Mr. Kennedy founded Children’s Health Defense, a nonprofit that aims to end childhood health epidemics by promoting vaccine safeguards, among other initiatives.

Last year, Mr. Kennedy told podcaster Joe Rogan that ivermectin was suppressed by the FDA so that the COVID-19 vaccines could be granted emergency use authorization.

He has criticized Big Pharma, vaccine safety, and government mandates for years.

Since launching his presidential campaign, Mr. Kennedy has made his stances on the COVID-19 vaccines, and vaccines in general, a frequent talking point.

“I would argue that the science is very clear right now that they [vaccines] caused a lot more problems than they averted,” Mr. Kennedy said on Piers Morgan Uncensored last April.

“And if you look at the countries that did not vaccinate, they had the lowest death rates, they had the lowest COVID and infection rates.”

Additional data show a “direct correlation” between excess deaths and high vaccination rates in developed countries, he said.

President Trump and Mr. Kennedy have similar views on topics like protecting the U.S.-Mexico border and ending the Russia-Ukraine war.

COVID-19 is the topic where Mr. Kennedy and President Trump seem to differ the most.

Former President Donald Trump intended to “drain the swamp” when he took office in 2017, but he was “intimidated by bureaucrats” at federal agencies and did not accomplish that objective, Mr. Kennedy said on Feb. 5.

Speaking at a voter rally in Tucson, where he collected signatures to get on the Arizona ballot, the independent presidential candidate said President Trump was “earnest” when he vowed to “drain the swamp,” but it was “business as usual” during his term.

John Bolton, who President Trump appointed as a national security adviser, is “the template for a swamp creature,” Mr. Kennedy said.

Scott Gottlieb, who President Trump named to run the FDA, “was Pfizer’s business partner” and eventually returned to Pfizer, Mr. Kennedy said.

Mr. Kennedy said that President Trump had more lobbyists running federal agencies than any president in U.S. history.

“You can’t reform them when you’ve got the swamp creatures running them, and I’m not going to do that. I’m going to do something different,” Mr. Kennedy said.

During the COVID-19 pandemic, President Trump “did not ask the questions that he should have,” he believes.

President Trump “knew that lockdowns were wrong” and then “agreed to lockdowns,” Mr. Kennedy said.

He also “knew that hydroxychloroquine worked, he said it,” Mr. Kennedy explained, adding that he was eventually “rolled over” by Dr. Anthony Fauci and his advisers.

President Donald Trump greets the crowd before he leaves at the Operation Warp Speed Vaccine Summit in Washington on Dec. 8, 2020. (Tasos Katopodis/Getty Images)

MaryJo Perry, a longtime advocate for vaccine choice and a Trump supporter, thinks votes will be at a premium come Election Day, particularly because the independent and third-party field is becoming more competitive.

Ms. Perry, president of Mississippi Parents for Vaccine Rights, believes advocates for medical freedom could determine who is ultimately president.

She believes that Mr. Kennedy is “pulling votes from Trump” because of the former president’s stance on the vaccines.

“People care about medical freedom. It’s an important issue here in Mississippi, and across the country,” Ms. Perry told The Epoch Times.

“Trump should admit he was wrong about Operation Warp Speed and that COVID vaccines have been dangerous. That would make a difference among people he has offended.”

President Trump won’t lose enough votes to Mr. Kennedy about Operation Warp Speed and COVID vaccines to have a significant impact on the election, Ohio Republican strategist Wes Farno told The Epoch Times.

President Trump won in Ohio by eight percentage points in both 2016 and 2020. The Ohio Republican Party endorsed President Trump for the nomination in 2024.

“The positives of a Trump presidency far outweigh the negatives,” Mr. Farno said. “People are more concerned about their wallet and the economy.

“They are asking themselves if they were better off during President Trump’s term compared to since President Biden took office. The answer to that question is obvious because many Americans are struggling to afford groceries, gas, mortgages, and rent payments.

“America needs President Trump.”

Multiple national polls back Mr. Farno’s view.

As of March 6, the RealClearPolitics average of polls indicates that President Trump has 41.8 percent support in a five-way race that includes President Biden (38.4 percent), Mr. Kennedy (12.7 percent), independent Cornel West (2.6 percent), and Green Party nominee Jill Stein (1.7 percent).

A Pew Research Center study conducted among 10,133 U.S. adults from Feb. 7 to Feb. 11 showed that Democrats and Democrat-leaning independents (42 percent) are more likely than Republicans and GOP-leaning independents (15 percent) to say they have received an updated COVID vaccine.

The poll also reported that just 28 percent of adults say they have received the updated COVID inoculation.

The peer-reviewed multinational study of more than 99 million vaccinated people that Mr. Kennedy referenced in his X post on March 7 was published in the Vaccine journal on Feb. 12.

It aimed to evaluate the risk of 13 adverse events of special interest (AESI) following COVID-19 vaccination. The AESIs spanned three categories—neurological, hematologic (blood), and cardiovascular.

The study reviewed data collected from more than 99 million vaccinated people from eight nations—Argentina, Australia, Canada, Denmark, Finland, France, New Zealand, and Scotland—looking at risks up to 42 days after getting the shots.

Three vaccines—Pfizer and Moderna’s mRNA vaccines as well as AstraZeneca’s viral vector jab—were examined in the study.

Researchers found higher-than-expected cases that they deemed met the threshold to be potential safety signals for multiple AESIs, including for Guillain-Barre syndrome (GBS), cerebral venous sinus thrombosis (CVST), myocarditis, and pericarditis.

A safety signal refers to information that could suggest a potential risk or harm that may be associated with a medical product.

The study identified higher incidences of neurological, cardiovascular, and blood disorder complications than what the researchers expected.

President Trump’s role in Operation Warp Speed, and his continued praise of the COVID vaccine, remains a concern for some voters, including those who still support him.

Krista Cobb is a 40-year-old mother in western Ohio. She voted for President Trump in 2020 and said she would cast her vote for him this November, but she was stunned when she saw his response to President Biden about the COVID-19 vaccine during the State of the Union address.

I love President Trump and support his policies, but at this point, he has to know they [advisers and health officials] lied about the shot,” Ms. Cobb told The Epoch Times.

“If he continues to promote it, especially after all of the hearings they’ve had about it in Congress, the side effects, and cover-ups on Capitol Hill, at what point does he become the same as the people who have lied?” Ms. Cobb added.

“I think he should distance himself from talk about Operation Warp Speed and even admit that he was wrong—that the vaccines have not had the impact he was told they would have. If he did that, people would respect him even more.”

Tyler Durden Mon, 03/11/2024 - 17:00

Read More

Continue Reading

Trending